Serum vitamin B12-binding capacity and muramidase changes with cyclic neutropenia induced by cytosine arabinoside.
D000328:Adult; D000380:Agranulocytosis / Q000097:blood* / Q000139:chemically induced / Q000201:enzymology; D000510:Alpha-Globulins / Q000378:metabolism; D001609:Beta-Globulins / Q000378:metabolism; D001772:Blood Cell Count; D001797:Blood Protein Electrophoresis; D001856:Bone Marrow Examination; D003036:Cobalt Isotopes; D003561:Cytarabine / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000097:blood / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009113:Muramidase / Q000097:blood*; D010507:Periodicity; D011485:Protein Binding; D014805:Vitamin B 12 / Q000097:blood*
D000510:Alpha-Globulins; D001609:Beta-Globulins; D003036:Cobalt Isotopes; D003561:Cytarabine; D009113:Muramidase; D014805:Vitamin B 12